Sensei Biotherapeutics Inc.
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 24 institutions reported holding Sensei Biotherapeutics Inc. in their 13F filings, up 5 from Q3 2024. 4 opened new positions and 1 sold out. The largest holders were Ikarian Capital, LLC ($319K), Vanguard Group Inc. ($291K) and Catalio Capital Management, LP ($144K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sensei Biotherapeutics Inc.
- CUSIP
- 81728A108
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $13K |
| Exits | 1 | $27K |
All 13F filers, Q3 2024 → Q4 2024: 77,253 shares bought and 208,385 shares sold, net −131,132 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Ikarian Capital, LLC | 0.09% | Reduce -0.0% | 649,963 | $319K |
| Vanguard Group Inc. | 0.00% | Reduce -3.9% | 594,454 | $291K |
| Catalio Capital Management, LP | 0.03% | — | 294,374 | $144K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -0.0% | 172,798 | $85K |
| Renaissance Technologies | 0.00% | Reduce -27.3% | 156,800 | $77K |
| Geode Capital Management, LLC | 0.00% | Reduce -8.7% | 148,887 | $73K |
| XTX Topco Ltd | 0.00% | Add +351.7% | 62,903 | $31K |
| Citadel Advisors | 0.00% | Reduce -12.6% | 57,717 | $28K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 47,900 | $23K |
| Susquehanna International Group, LLP | 0.00% | Reduce -57.9% | 38,051 | $19K |
| Northern Trust Corp. | 0.00% | No change | 25,983 | $13K |
| State Street Corp. | 0.00% | No change | 25,774 | $13K |
| Cresset Asset Management, LLC | 0.00% | No change | 19,671 | $10K |
| NWF Advisory Services Inc. | 0.00% | New | 16,514 | $8K |
| Raymond James Financial Inc. | 0.00% | — | 14,000 | $7K |
| Deuterium Capital Management, LLC | 0.01% | No change | 11,000 | $5K |
| HRT Financial LP | 0.00% | New | 11,600 | $5K |
| Morgan Stanley | 0.00% | Reduce -24.6% | 9,219 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -22.5% | 5,448 | $3K |
| JPMorgan Chase & Co. | 0.00% | Reduce -0.3% | 705 | $345 |
| BNP Paribas Financial Markets | 0.00% | New | 160 | $78 |
| Bank of America Corp. | 0.00% | Reduce -47.3% | 136 | $67 |
| SBI Securities Co., Ltd. | 0.00% | — | 71 | $35 |
| UBS Group AG | 0.00% | New | 2 | $1 |
"% of holder's portfolio" is SENSEI BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Sensei Biotherapeutics Inc. the manager owns.